📰 14 sources covering this story

Amazon to Offer GLP-1 Weight-Loss Drugs to Medicare Part D Patients - WSJ

First covered 6 days ago · latest take 1 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

Amazon to Offer GLP-1 Weight-Loss Drugs to Medicare Part D Patients - WSJ
Amazon to Offer GLP-1 Weight-Loss Drugs to Medicare Part D Patients - WSJ
Amazon to Offer GLP-1 Weight-Loss Drugs to Medicare Part D Patients  WSJ
The Times
The Times1 days ago
Health fear over growing misuse of weight-loss drugs in elite sport
Health fear over growing misuse of weight-loss drugs in elite sport  The Times
Fortune
Fortune2 days ago
Bank of America is splashing out $250 million a year on weight loss drugs for its staff: ‘We see a great impact on employees,’ CEO says
Weight-loss drugs are becoming a popular perk, with almost a third of workers saying they’d even switch jobs for it. Bank of America has them covered.
Quartz
Quartz2 days ago
Amazon Pharmacy is offering Medicare patients weight loss drugs for $50 a month
Amazon joins the federal Medicare GLP-1 Bridge Program, automating prior authorization and offering same-day delivery in more than 3,100 cities
The Independent
The Independent3 days ago
Major bank CEO says company spends $250 million a year on GLP-1 drugs for its employees
GLP-1 drugs for weight loss are on the rise, with 11 percent of Americans saying they take one in a recent poll
Newsweek
Newsweek3 days ago
How to Get GLP-1 Weight Loss Drugs for $50: List of Major Pharmacies
Amazon Pharmacy said Thursday it has become one of the latest major providers offering the medication under a Medicare program.
Fox News
Fox News3 days ago
Tim McGraw and Faith Hill's daughter says weight-loss drugs led to the return of her eating disorder
Gracie McGraw reveals how Ozempic brought back her eating disorder after being prescribed the weight loss drug for her PCOS diagnosis in 2022.
The Mirror
The Mirror3 days ago
'Do not buy this product' Dr Amir Khan weight loss drug warning message
The NHS GP is urging people to avoid the product after he received messages about it from followers and family members
Euronews
Euronews4 days ago
Weight-loss drugs tied to lower fracture risk in diabetes patients, study finds
Weight-loss medicines linked to 21% lower fracture risk in type 2 diabetes patients, a new study found, challenging assumptions that rapid weight loss inevitably raises fracture risk.
MarketWatch
MarketWatch4 days ago
How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?
The Danish company developed the most lucrative new drug the world had ever seen. Then America’s Eli Lilly outmaneuvered it and took control of the diet-drug market.
New York Post
New York Post4 days ago
Some patients to score new super-effective ‘Triple G’ weight loss drug — before FDA approval
Retatrutide — also known as "reta" — has been shown to produce dramatically greater weight loss than Ozempic and Mounjaro.
RNZ
RNZ5 days ago
Weight loss drugs could boost chances of getting a job
International research suggests losing weight may help people get a job - and their New Zealand counterparts say it can't be ruled out here, either.
CBS News
CBS News5 days ago
Access expanding for experimental weight loss drug
Drugmaker Eli Lilly says it is expanding access to its experimental weight loss drug, retatrutide, which has not been approved yet by the FDA. The company says obese patients taking the drug in clinical trials lost between 73 and 85 pounds over two years. Dr. Rachel Pessah Pollack discusses what we know about its safet
Stuff
Stuff🏁 first to report6 days ago
‘My doctor said I could die’: Flight attendant lost a quarter of her body weight after taking illegal weight loss drugs
Jaime says TikTok taught her how to buy and inject black market peptides. Months later, she had lost 17kg.